Public trial registry of the CCC-Munich

Trial FIRE-4.5

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
FIRE-4.5
World
Full title
:

Randomisierte Studie zur Untersuchung FOLFOXIRI plus Cetuximab vs. FOLFOXIRI plus Bevacizumab als First-line Therapie des BRAF mutierten metastasierten kolorektalen Karzinom.

World
EudraCT number
:
World
Responsible organization
:
RoMed-Klinikum Rosenheim, Telefon: 080313653850
Indications
Classification Code Description
ICD-10-GM C18.- Bösartige Neubildung des Kolons
- Colorectal carcinoma
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Blinded
World
Phase
:
II
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2023-12-31 / 2021-03-31
Therapy
World
Therapy line
:
1
Participants
Function Prename Surname Organization